Michael Burke, MD
Psychiatry · Atlanta, GANPI 1376649962
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $187,830 of the $216,590 with a category attached, or 86.7%. Alkermes, Inc. accounts for 99.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $96,591 and has fallen 82.2% since, to $17,152 in 2024. Among psychiatry clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 220 payments — averaging $984.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$216K
- Theragen, Inc.$127
- Ironshore Pharmaceuticals Inc.$35
- Otsuka America Pharmaceutical, Inc.$17
Across 15 payments — averaging $7426.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$111K
- Alkermes, Inc.$170
What the payments were for
- Consulting fees$6,8003%
- Speaking & faculty fees$187,83087%
- Travel & lodging$17,2138%
- Food & beverage$4,7472%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 217 | $216,410 |
| Theragen, Inc. | 1 | $127 |
| Ironshore Pharmaceuticals Inc. | 1 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$721,894
- ARISTADA$109,603
- ARISTADA INITIO$16,255
- ActaStim-S$127
How this compares
$216,590 in reported general payments places this provider in the 95th percentile of 900 psychiatry providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Paliperidone ErPaliperidone | 13 | $889 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $595 |
| Aripiprazole | 27 | $558 |
| Olanzapine | 34 | $549 |
| Ziprasidone Hcl | 12 | $378 |
| Haloperidol | 16 | $350 |
| Quetiapine Fumarate | 32 | $296 |
| Buspirone Hcl | 25 | $282 |
| Hydroxyzine Pamoate | 22 | $232 |
| Duloxetine Hcl | 18 | $221 |
| Benztropine Mesylate | 24 | $198 |
| Gabapentin | 14 | $170 |
| Mirtazapine | 20 | $160 |
| Fluoxetine Hcl | 30 | $143 |
| Prazosin Hcl | 17 | $113 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Atlanta
- David PurselleAtlanta$307K
- Bryon EvansAtlanta$211K
- Kerry ResslerAtlanta$196K
- Patricio Riva PosseAtlanta$122K
- Ray HorwitzAtlanta$64K
- Boadie DunlopAtlanta$61K
- Zohaib HaqueAtlanta$49K
- Raymond KotwickiAtlanta$44K
- Joseph BergerAtlanta$24K
- Dwight OwensAtlanta$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.